The Toronto-Dominion Bank
TD
TC Energy Corp
TRP
BCE Inc
BCE
Enbridge Inc
ENB
Emera Inc
EMA
CA Stock MarketDetailed Quotes
QNTM Quantum BioPharma Ltd
- 4.900
- +0.140+2.94%
15min DelayMarket Closed Jan 17 15:45 ET
9.41MMarket Cap-0.27P/E (TTM)
4.900High4.700Low1.03KVolume4.800Open4.760Pre Close4.86KTurnover12.22052wk High0.06%Turnover Ratio1.92MShares3.90052wk Low-17.832EPS TTM7.82MFloat Cap12.220Historical HighLossP/E (Static)1.59MShs Float3.900Historical Low-39.637EPS LYR4.20%Amplitude--Dividend TTM0.40P/B1Lot Size--Div YieldTTM
Quantum BioPharma Ltd Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 60.18%-10.83M | 86.54%-851.65K | 77.21%-1.71M | 59.94%-3.51M | -3.59%-4.75M | -40.42%-27.19M | -60.76%-6.33M |
| Net income from continuing operations | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M | 84.13%-1.13M | 31.07%-5.49M | -82.34%-9.96M | 21.32%-26.7M | 0.24%-6.15M |
| Operating gains losses | -3,341.25%-260.34K | 150.18%164.68K | 133.89%484.04K | -244.50%-595.77K | -165.72%-482.56K | -98.89%8.03K | -205.21%-328.19K | 146.76%206.95K | 160.41%412.29K | 72.63%-181.6K |
| Depreciation and amortization | -17.71%120.81K | -87.65%136.81K | -89.37%120.14K | -44.73%2.51M | -89.41%122.22K | -87.19%146.81K | -2.28%1.11M | 2.61%1.13M | 12.09%4.53M | 4.23%1.15M |
| Asset impairment expenditure | --0 | --0 | --0 | --4.56M | --236.19K | --0 | --3.84M | --480.1K | --0 | --0 |
| Unrealized gains and losses of investment securities | --0 | --0 | --0 | 61.56%378.43K | 253.96%103.26K | -48.70%-2.17K | -45.25%100.05K | 47.70%177.28K | -72.72%234.23K | -109.89%-67.07K |
| Remuneration paid in stock | -48.14%65.42K | -72.35%111.52K | -98.20%57.74K | 150.48%3.84M | -80.38%99.38K | -78.49%126.16K | 13.63%403.39K | 3,755.82%3.21M | -79.43%1.53M | 48.31%506.58K |
| Other non cashItems | 100.52%10.37K | 100.29%8.36K | 423.14%12.41K | -6,147.98%-4.91M | 118.26%3.09K | -11,099.61%-2.01M | -15,227.04%-2.91M | 103.76%2.37K | -501.09%-78.66K | -157.90%-16.91K |
| Change In working capital | -46.04%618.21K | 1,126.30%2.32M | -245,168.28%-556.31K | 123.00%1.64M | 145.67%718.33K | 140.56%1.15M | 91.90%-226.51K | -99.69%227 | -346.49%-7.12M | -314.01%-1.57M |
| -Change in receivables | -220.15%-524.65K | 232.14%1.15M | 349.13%610.74K | 89.90%-728.72K | 96.59%-49.7K | 114.51%436.67K | 66.25%-870.54K | -43.69%-245.15K | -6,651.95%-7.22M | -1,539.51%-1.46M |
| -Change in prepaid assets | -112.90%-19.9K | -57.39%142.67K | 67.79%-117.68K | -60.21%316.72K | -66.98%192.95K | -59.85%154.32K | 1,404.71%334.86K | -87.37%-365.4K | 230.66%795.93K | 1,475.19%584.31K |
| -Change in payables and accrued expense | 109.60%1.16M | 233.69%1.03M | -271.81%-1.05M | 392.92%2.05M | --575.08K | --554.77K | 229.63%309.17K | 39.24%610.78K | -119.41%-699.78K | ---- |
| Cash from discontinued investing activities | 0 | 17.30%-1.14M | 0 | |||||||
| Operating cash flow | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 61.79%-10.83M | 86.54%-851.65K | 77.21%-1.71M | 62.66%-3.51M | 6.66%-4.75M | -36.57%-28.33M | -54.64%-6.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,184.78%-3.46M | 738.22K | -22.14K | 55.63%-269.58K | 0 | -178.15%-269.58K | 0 | 0 | -325.88%-607.53K | -919.64%-392.53K |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---113.96K | --2.92K |
| Net intangibles purchas and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 50.00%-250K | --0 |
| Net business purchase and sale | ---- | ---- | ---- | --31.78K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | -1,049.28%-3.46M | --738.22K | ---22.14K | -23.72%-301.36K | --0 | ---301.36K | --0 | --0 | ---243.58K | ---395.45K |
| Cash from discontinued investing activities | 0 | 12.73M | 0 | |||||||
| Investing cash flow | -1,184.78%-3.46M | --738.22K | ---22.14K | -102.22%-269.58K | --0 | -178.15%-269.58K | --0 | --0 | 4,407.45%12.12M | -919.64%-392.53K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 12,400.66%6.74M | 4,378.90%1.84M | 118.94%568.72K | -51.09%-3.13M | 49.10%-25.22K | 78.75%-54.78K | 84.34%-43.11K | -102.02%-3M | -105.42%-2.07M | -283.67%-49.54K |
| Net issuance payments of debt | -461.21%-307.41K | 102.39%1.31K | 601.31%272.28K | -32.14%-189.05K | 49.03%-25.25K | -35.38%-54.78K | -32.70%-54.71K | -358.81%-54.31K | -10.63%-143.07K | -283.67%-49.54K |
| Net common stock issuance | --7.05M | --1.84M | 110.02%296.44K | -53.55%-2.96M | --34 | --0 | --0 | -100.54%-2.96M | -105.02%-1.93M | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --20.25K | --0 | --0 | --11.6K | --8.65K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 12,400.66%6.74M | 4,378.90%1.84M | 118.94%568.72K | -51.09%-3.13M | 49.10%-25.22K | 78.75%-54.78K | 84.34%-43.11K | -102.02%-3M | -105.42%-2.07M | -283.67%-49.54K |
| Net cash flow | ||||||||||
| Beginning cash position | -41.69%3.31M | -85.58%1.33M | -83.76%2.76M | -51.84%16.98M | -84.70%3.63M | -82.07%5.67M | -67.72%9.22M | -51.84%16.98M | 101.20%35.26M | -39.59%23.75M |
| Current changes in cash | 90.85%-186.42K | 155.64%1.98M | 81.61%-1.43M | 22.19%-14.22M | 87.04%-876.87K | 74.12%-2.04M | -216.61%-3.55M | -16.01%-7.76M | -203.07%-18.28M | -66.88%-6.77M |
| End cash Position | -14.14%3.12M | -41.69%3.31M | -85.58%1.33M | -83.76%2.76M | -83.76%2.76M | -84.70%3.63M | -82.07%5.67M | -67.72%9.22M | -51.84%16.98M | -51.84%16.98M |
| Free cash from | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 62.27%-10.83M | 86.53%-851.65K | 77.50%-1.71M | 62.68%-3.51M | 11.27%-4.75M | -35.07%-28.7M | -56.40%-6.32M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.